Aurobindo Pharma Balance Sheet Health
Financial Health criteria checks 6/6
Aurobindo Pharma has a total shareholder equity of ₹281.9B and total debt of ₹66.5B, which brings its debt-to-equity ratio to 23.6%. Its total assets and total liabilities are ₹439.2B and ₹157.3B respectively. Aurobindo Pharma's EBIT is ₹36.8B making its interest coverage ratio 38.4. It has cash and short-term investments of ₹71.5B.
Key information
23.6%
Debt to equity ratio
₹66.49b
Debt
Interest coverage ratio | 38.4x |
Cash | ₹71.49b |
Equity | ₹281.95b |
Total liabilities | ₹157.29b |
Total assets | ₹439.24b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 524804's short term assets (₹235.6B) exceed its short term liabilities (₹130.1B).
Long Term Liabilities: 524804's short term assets (₹235.6B) exceed its long term liabilities (₹27.2B).
Debt to Equity History and Analysis
Debt Level: 524804 has more cash than its total debt.
Reducing Debt: 524804's debt to equity ratio has reduced from 42.7% to 23.6% over the past 5 years.
Debt Coverage: 524804's debt is well covered by operating cash flow (30%).
Interest Coverage: 524804's interest payments on its debt are well covered by EBIT (38.4x coverage).